HCSC(SH:600378)2025-04-29 16:20Financial Performance - The company's operating revenue for Q1 2025 reached ¥3,156,902,838.56, representing a year-on-year increase of 10.96% compared to ¥2,845,099,846.77 in the same period last year[3] - Net profit attributable to shareholders was ¥184,741,510.38, up 10.53% from ¥167,134,125.97 in the previous year[3] - The net profit after deducting non-recurring gains and losses was ¥171,298,757.04, reflecting a significant increase of 26.02% compared to the previous year's figure[3] - The basic and diluted earnings per share decreased by 5.60% to ¥0.1433 from ¥0.1518 in the same period last year[4] - Net profit for Q1 2025 was ¥213,729,247.30, compared to ¥175,657,298.21 in Q1 2024, representing a growth of 21.66%[24] - The total comprehensive income for the first quarter of 2025 reached CNY 215,307,461.12, an increase from CNY 176,679,722.88 in the same period of 2024, representing a growth of approximately 21.8%[25] Assets and Liabilities - Total assets at the end of the reporting period amounted to ¥30,565,032,169.54, an increase of 1.37% from ¥30,151,420,225.36 at the end of the previous year[4] - Total liabilities rose to ¥12,766,759,417.03 in 2025, up from ¥12,579,808,029.06 in 2024, indicating an increase of 1.49%[20] - The company's total assets increased to ¥30,565,032,169.54 in 2025 from ¥30,151,420,225.36 in 2024, marking a growth of 1.37%[20] - The total equity attributable to shareholders increased to ¥17,316,068,133.72 in 2025 from ¥17,118,862,583.15 in 2024, reflecting a growth of 1.15%[20] Cash Flow - The net cash flow from operating activities was negative at -¥139,794,495.08, compared to -¥346,041,501.57 in the previous year, indicating an improvement[3] - As of March 31, 2025, the company's cash and cash equivalents amounted to RMB 4.864 billion, down from RMB 5.457 billion at the end of 2024[17] - Cash inflow from operating activities totaled CNY 3,194,792,619.55 in Q1 2025, up from CNY 2,910,936,429.76 in Q1 2024, indicating a growth of about 9.8%[28] - The net cash flow from investing activities for Q1 2025 was -CNY 451,139,864.48, slightly improved from -CNY 545,776,178.57 in Q1 2024[29] - The total cash and cash equivalents at the end of Q1 2025 were CNY 4,667,706,512.92, compared to CNY 2,259,625,011.69 at the end of Q1 2024, showing a significant increase of approximately 106.5%[30] Operational Highlights - The high-end fluorine materials segment saw a gross profit increase of 42.9%, with a gross margin improvement of 3.1 percentage points[14] - The electronic gas business experienced a gross profit growth of 25.6%, with a gross margin increase of 1.4 percentage points[14] - The high-end manufacturing chemical materials segment's gross profit decreased by 18.6%, with a gross margin reduction of 8.7 percentage points[14] - Key projects are progressing as planned, including the completion of a 1,000-ton per year perfluoroolefin project and a 26,000-ton per year high-performance organic fluorine materials project[15] Shareholder Information - The company reported a total of 16,303 common shareholders at the end of the reporting period[10] Research and Development - The company has newly approved 2 national-level R&D platforms and received certification for its domestically produced aircraft tire[14] - Research and development expenses for Q1 2025 were ¥184,588,586.17, slightly down from ¥189,402,001.61 in Q1 2024, a decrease of 1.66%[23] Financial Adjustments - The financial data for the previous year was adjusted due to the merger with Zhonghua Lantian Group and Guilin Lanyu Aviation Tire Development Co., Ltd.[5]